Individualized pharmacogenomics for depressive episodes: A narrative review.
This narrative review aims to summarize key pharmacogenes and genetic variants implicated in the pharmacological treatment of MDD and differentiate genes with established clinical actionability from those requiring further evidence, and evaluate their current and future roles in precision psychiatry.